Technology offers

The OTT-SSPA offers the access service to all the technologies developed by the Andalusian Public Healthcare System, including patents, utility models, know-how and software. This space features all the technologies available in our Catalogue of Technology Offers We include over 50 new offers every year. If you cannot find what you are looking for, you can contact us here.

BIOMARKERS FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS)
A research group from the Andalusian Public Health System (SSPA) has developed a kit for the diagnosis, prognosis and / or monitoring of Amyotrophic Lateral Sclerosis (ALS).
KIT FOR PREDICTING THE RESPONSE TO TREATMENT WITH MSCS IN PATIENTS WITH INFLAMMATORY DISEASES
A research group from Andalusian Public Health System has developed a kit for predicting the response to treatment with Mesenchymal Stem Cells (MSCs) in patients with inflammatory diseases.
USE OF NESTIN+ CELLS FOR DIFFERENTIATION TO MESODERM-DERIVED CELLS AND THE MAINTENANCE OF HAEMATOPOIESIS POYESIS
A research group of the Andalusian Public Health System has managed to demonstrate that Nestin+ cells can behave like mesenchymal stem cells. Which are capable of differentiating to osteocytes.
METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF VASCULAR PARKINSONISM AND PARKINSON'S DISEASE
A research group of the Andalusian Public Health System (SSPA) has developed a computer-implemented method for the differential diagnosis of vascular parkinsonism (VP) and Parkinson's disease (PD) as a clinical decision support tool.
´SMART SYSTEM FOR ADAPTIVE BRONCHIAL HYGIENIC THERAPIES FOR THE TREATMENT OF CHRONIC RESPIRATORY DISEASES (VITHA-CHEST)
A research group of the Andalusian Public Health System, in collaboration with the companies Altran Innovación, TicTouch and Sesid, has developed a smart system equipped with technological innovative systems for the treatment of chronic respiratory diseases.
USE OF DERIVATIVES OF ANTHRANILIC ACID ON THE PRODUCTION OF A MEDICINE FOR CHOLESTASIS TREATMENT
A research group from the Andalusian Public Healthcare System has discovered a new therapeutic agent for the chronic liver disease (CLD).
USE OF DERIVATIVES OF AUREOLIC ACID ON THE PRODUCTION OF A MEDICINE FOR CHOLESTASIS TREATMENT
A research group from the Andalusian Public Healthcare System has discovered a new therapeutic agent for the chronic liver disease (CLD).
DIAGNOSIS KIT FOR THE IDENTIFICATION OF BACTERIAL AGENTS CAUSING SYSTEMIC INFECTIONS
A research group from the Andalusian Public Health System (SSPA) has devised a diagnosis kit for identifying bacterial agents causing systemic infections.
BIOMARKERS IN EXHALED BREATH CONDENSATE FOR THE DIAGNOSIS, CLASSIFICATION AND MONITORING OF LUNG CANCER
A research group from the Andalusian Public Health System (SSPA) has discovered biomarkers in condensed exhaled breath that allow the diagnosis, classification and monitoring of lung cancer.
METHOD FOR OBTAINING USEFUL DATA FOR HEPATOCELLULAR CARCINOMA IN ALCOHOLIC PATIENTS SUFFERING FROM HEPATITIS C
A research group of the Public Health Sysmte of Andalusia (SSPA) has developed a kit and method of obtaining useful data for diagnosing hepatocellular carcinoma in alcoholic patients with hepatitis C.

Pages